Posted by Michael Wonder on 31 Jul 2026
Wegovy’s PBS listing would have been landmark. Now it’s in doubt.
1 August 2026 - The GLP-1 drug was recommended for listing on the PBS for certain patients over seven months ago.
Now the landmark deal has stalled.
